Skip to main content

INNOVACION TERAPEUTICA EN ENFERMEDAD DE MCARDLE: TERAPIA SUSTITUTIVA DE MIOFOSFORILASA MEDIANTE VEHICULOS LIPOSOMICOS.

PI17/02052

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2017
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE
Execution centre INSTITUTO DE INVESTIGACION HOSPITAL 12 DE OCTUBRE (i+12)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Low aerobic capacity in McArdle disease, A role for mitochondrial network impairment?

  • Villarreal-Salazar, Mónica|||0000-0002-8794-691X
  • Santalla, Alfredo|||0000-0001-9418-0564
  • Real-Martinez, Alberto|||0000-0002-4703-5142
  • Nogales, Gisela|||0000-0002-7414-212X
  • Valenzuela, P.L.
  • Fiuza-Luces, Carmen
  • Andreu, A. L.
  • Rodríguez Aguilera, Juan Carlos|||0000-0002-3371-4128
  • Martín, M.A.
  • Arenas, Joaquín|||0000-0002-2877-5049
  • Vissing, John|||0000-0001-6144-8544
  • Lucia, Alejandro|||0000-0002-3025-2060
  • Krag, Thomas|||0000-0001-9330-668X
  • Pinós Figueras, Tomàs|||0000-0002-4379-0917
McArdle disease is caused by myophosphorylase deficiency and results in complete inability for muscle glycogen breakdown. A hallmark of this condition is muscle oxidation impairment (e.g., low peak oxygen uptake (VO)), a phenomenon traditionally attributed to reduced glycolytic flux and Krebs cycle anaplerosis. Here we hypothesized an additional role for muscle mitochondrial network alterations associated with massive intracellular glycogen accumulation. We analyzed in depth mitochondrial characteristics-content, biogenesis, ultrastructure-and network integrity in skeletal-muscle from McArdle/control mice and two patients. We also determined VO in patients (both sexes, N = 145) and healthy controls (N = 133). Besides corroborating very poor VO values in patients and impairment in muscle glycolytic flux, we found that, in McArdle muscle: (a) damaged fibers are likely those with a higher mitochondrial and glycogen content, which show major disruption of the three main cytoskeleton components-actin microfilaments, microtubules and intermediate filaments-thereby contributing to mitochondrial network disruption in skeletal muscle fibers; (b) there was an altered subcellular localization of mitochondrial fission/fusion proteins and of the sarcoplasmic reticulum protein calsequestrin-with subsequent alteration in mitochondrial dynamics/function; impairment in mitochondrial content/biogenesis; and (c) several OXPHOS-related complex proteins/activities were also affected. In McArdle disease, severe muscle oxidative capacity impairment could also be explained by a disruption of the mitochondrial network, at least in those fibers with a higher capacity for glycogen accumulation. Our findings might pave the way for future research addressing the potential involvement of mitochondrial network alterations in the pathophysiology of other glycogenoses.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification of Potential Muscle Biomarkers in McArdle Disease, Insights from Muscle Proteome Analysis

  • García-Consuegra, Inés
  • Asensio-Peña, Sara|||0000-0002-2048-5899
  • Garrido-Moraga, Rocío|||0000-0002-2856-4399
  • Pinós Figueras, Tomàs|||0000-0002-4379-0917
  • Domínguez-González, Cristina|||0000-0001-5151-988X
  • Santalla, Alfredo|||0000-0001-9418-0564
  • Nogales, Gisela|||0000-0002-7414-212X
  • Serrano-Lorenzo, Pablo|||0000-0002-5661-7574
  • Andreu Périz, Antoni Lluís
  • Arenas, Joaquín|||0000-0002-2877-5049
  • Zugaza, José L.|||0000-0002-9000-6398
  • Lucia, Alejandro|||0000-0002-3025-2060
  • Martín, Miguel A.|||0000-0003-4741-772X
Glycogen storage disease type V (GSDV, McArdle disease) is a rare genetic myopathy caused by deficiency of the muscle isoform of glycogen phosphorylase (PYGM). This results in a block in the use of muscle glycogen as an energetic substrate, with subsequent exercise intolerance. The pathobiology of GSDV is still not fully understood, especially with regard to some features such as persistent muscle damage (i.e., even without prior exercise). We aimed at identifying potential muscle protein biomarkers of GSDV by analyzing the muscle proteome and the molecular networks associated with muscle dysfunction in these patients. Muscle biopsies from eight patients and eight healthy controls showing none of the features of McArdle disease, such as frequent contractures and persistent muscle damage, were studied by quantitative protein expression using isobaric tags for relative and absolute quantitation (iTRAQ) followed by artificial neuronal networks (ANNs) and topology analysis. Protein candidate validation was performed by Western blot. Several proteins predominantly involved in the process of muscle contraction and/or calcium homeostasis, such as myosin, sarcoplasmic/endoplasmic reticulum calcium ATPase 1, tropomyosin alpha-1 chain, troponin isoforms, and alpha-actinin-3, showed significantly lower expression levels in the muscle of GSDV patients. These proteins could be potential biomarkers of the persistent muscle damage in the absence of prior exertion reported in GSDV patients. Further studies are needed to elucidate the molecular mechanisms by which PYGM controls the expression of these proteins.